This Article Full Text Full Text (PDF) Supplemental Data File All Versions of this Article: 20/5/1177    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, J. Articles by Ormandy, C. J. Search for Related Content PubMed PubMed Citation Articles by Harris, J. Articles by Ormandy, C. J.

Socs2 and Elf5 Mediate Prolactin-Induced Mammary Gland Development

Garvan Institute of Medical Research (J.H., P.M.S., S.R.O., M.J.N., F.G.R., K.D.B., M.K., H.N.H., C.J.O.), St. Vincent’s Hospital Darlinghurst, New South Wales 2010, Australia; and Walter and Eliza Hall Institute of Medical Research (K.S., S.W., W.S.A., G.J.L., J.E.V.), Parkville, Victoria 3050, Australia

Address all correspondence and requests for reprints to: Christopher J. Ormandy, Garvan Institute of Medical Research, St. Vincent’s Hospital, Darlinghurst, New South Wales 2010, Australia. E-mail: c.ormandy{at}garvan.org.au.

The proliferative phase of mammary alveolar morphogenesis is initiated during early pregnancy by rising levels of serum prolactin and progesterone, establishing a program of gene expression that is ultimately responsible for the development of the lobuloalveoli and the onset of lactation. To explore this largely unknown genetic program, we constructed transcript profiles derived from transplanted mammary glands formed by recombination of prolactin receptor (Prlr) knockout or wild-type mammary epithelium with wild-type mammary stroma. Comparison with profiles derived from prolactin-treated Scp2 mammary epithelial cells produced a small set of commonly prolactin-regulated genes that included the negative regulator of cytokine signaling, Socs2 (suppressor of cytokine signaling 2), and the ets transcription factor, E74-like factor 5 (Elf5). Homozygous null mutation of Socs2 rescued the failure of lactation and reduction of mammary signal transducer and activator of transcription 5 phosphorylation that characterizes Prlr heterozygous mice, demonstrating that mammary Socs2 is a key regulator of the prolactin-signaling pathway. Reexpression of Elf5 in Prlr nullizygous mammary epithelium restored lobuloalveolar development and milk production, demonstrating that Elf5 is a transcription factor capable of substituting for prolactin signaling. Thus, Socs2 and Elf5 are key members of the set of prolactin-regulated genes that mediate prolactin-driven mammary development.

This article has been cited by other articles:

				L. Hennighausen and G. W. Robinson Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Genes & Dev., March 15, 2008; 22(6): 711 - 721. [Abstract] [Full Text] [PDF]

				S. R. Oakes, M. J. Naylor, M.-L. Asselin-Labat, K. D. Blazek, M. Gardiner-Garden, H. N. Hilton, M. Kazlauskas, M. A. Pritchard, L. A. Chodosh, P. L. Pfeffer, et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate Genes & Dev., March 1, 2008; 22(5): 581 - 586. [Abstract] [Full Text] [PDF]

				J. Derbinski, S. Pinto, S. Rosch, K. Hexel, and B. Kyewski Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism PNAS, January 15, 2008; 105(2): 657 - 662. [Abstract] [Full Text] [PDF]

				M. J. LeBaron, T. J. Ahonen, M. T. Nevalainen, and H. Rui In Vivo Response-Based Identification of Direct Hormone Target Cell Populations Using High-Density Tissue Arrays Endocrinology, March 1, 2007; 148(3): 989 - 1008. [Abstract] [Full Text] [PDF]